BALAXI PHARMACEUTICALS LIMITED Share Price & Analysis
₹25.37−1.67%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹25.37−1.67%Open
₹26.60High
₹26.60Low
₹24.93Close
₹25.3752W High
₹47.8052W Low
₹15.20Volume
51KLot Size
1Sector
HealthcareMarket Cap
₹140 CrFace Value
₹2Small Cap
Price Chart
Candle
Range
Fundamentals
P/E
57.60Sector P/E
54.70P/B
0.51EPS
₹0.40ROE
0.59%ROCE
3.11%D/E Ratio
—Div Yield
0.00%Book Value
₹45.10Strengths
- Trading below book value (P/B 0.5x)
Concerns
- Low capital efficiency (ROCE 3.1%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BALAXI · as of Jun 2026
Promoters65.99%
FII8.87%7.15pp
DII0.02%
Public25.12%7.16pp
| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 66.86% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| FII | 17.21% | 16.88% | 16.48% | 16.48% | 16.02% | 8.87% |
| DII | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 15.91% | 17.11% | 17.50% | 17.50% | 17.96% | 25.12% |
Latest News
All newsRelated Analysis
Frequently Asked Questions
What is BALAXI PHARMACEUTICALS LIMITED share price today?
BALAXI PHARMACEUTICALS LIMITED (BALAXI) is currently trading at ₹25.37 on NSE, down 1.67% as of the last market session. Prices update daily after market close on MarketNetra.
Is BALAXI PHARMACEUTICALS LIMITED available in F&O (Futures & Options)?
Yes, BALAXI PHARMACEUTICALS LIMITED (BALAXI) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is BALAXI PHARMACEUTICALS LIMITED 52-week high and low?
BALAXI PHARMACEUTICALS LIMITED's 52-week high is ₹47.8 and the 52-week low is ₹15.2. The current price of ₹25.37 is 46.9% below the 52W high.
What is BALAXI PHARMACEUTICALS LIMITED P/E ratio?
BALAXI PHARMACEUTICALS LIMITED's current P/E ratio is 57.6. This indicates the market is paying ₹57.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade BALAXI PHARMACEUTICALS LIMITED options?
BALAXI PHARMACEUTICALS LIMITED options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade BALAXI options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.